PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer

Although endocrine therapy is the most important treatment option in estrogen receptor (ER)-positive breast cancer, new strategies, such as molecular targeted agents together with endocrine therapy are required to improve survival. PIK3CA is the most frequent mutated gene in ER-positive early breast...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Ishida, Naoko, Baba, Motoi, Hatanaka, Yutaka, Hagio, Kanako, Okada, Hiromi, Hatanaka, Kanako C., Togashi, Kenichi, Matsuno, Yoshihiro, Yamashita, Hiroko
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2018
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915150/
https://ncbi.nlm.nih.gov/pubmed/29707142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24845
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia